MA
AMGN icon

Montag & Associates’s Amgen AMGN Stock Holding History

Montag & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$994K Sell
2,744
-200
-7% -$68.5K 0.04% 255
2026
Q1 		$1.04M Sell
2,944
-32
-1% -$11.4K 0.05% 243
2025
Q4 		$974K Buy
2,976
+108
+4% +$34.3K 0.04% 242
2025
Q3 		$809K Sell
2,868
-150
-5% -$43.5K 0.04% 265
2025
Q2 		$843K Sell
3,018
-320
-10% -$90.7K 0.04% 255
2025
Q1 		$1.04M Hold
3,338
– – 0.05% 236
2024
Q4 		$870K Sell
3,338
-363
-10% -$108K 0.04% 257
2024
Q3 		$1.19M Sell
3,701
-2,017
-35% -$660K 0.06% 230
2024
Q2 		$1.79M Sell
5,718
-57
-1% -$16.7K 0.09% 176
2024
Q1 		$1.64M Buy
5,775
+2,650
+85% +$775K 0.08% 194
2023
Q4 		$900K Sell
3,125
-37
-1% -$10.1K 0.05% 237
2023
Q3 		$850K Sell
3,162
-211
-6% -$52.7K 0.05% 236
2023
Q2 		$749K Hold
3,373
– – 0.05% 248
2023
Q1 		$815K Sell
3,373
-300
-8% -$73.6K 0.05% 233
2022
Q4 		$965K Sell
3,673
-93
-2% -$24.9K 0.06% 206
2022
Q3 		$849K Buy
3,766
+37
+1% +$8.97K 0.06% 217
2022
Q2 		$907K Sell
3,729
-96
-3% -$23.5K 0.06% 216
2022
Q1 		$925K Buy
3,825
+699
+22% +$161K 0.05% 234
2021
Q4 		$703K Hold
3,126
– – 0.03% 265
2021
Q3 		$665K Sell
3,126
-437
-12% -$101K 0.04% 266
2021
Q2 		$868K Sell
3,563
-400
-10% -$98.4K 0.05% 238
2021
Q1 		$986K Buy
3,963
+205
+5% +$48.9K 0.06% 221
2020
Q4 		$864K Buy
3,758
+138
+4% +$31.8K 0.05% 216
2020
Q3 		$920K Buy
3,620
+115
+3% +$28.5K 0.07% 185
2020
Q2 		$827K Hold
3,505
– – 0.07% 185
2020
Q1 		$711K Hold
3,505
– – 0.07% 192
2019
Q4 		$845K Hold
3,505
– – 0.07% 198
2019
Q3 		$678K Hold
3,505
– – 0.06% 202
2019
Q2 		$646K Sell
3,505
-597
-15% -$107K 0.06% 204
2019
Q1 		$779K Sell
4,102
-63
-2% -$12K 0.07% 190
2018
Q4 		$811K Hold
4,165
– – 0.09% 162
2018
Q3 		$863K Sell
4,165
-107
-3% -$21.1K 0.08% 191
2018
Q2 		$789K Sell
4,272
-1,348
-24% -$238K 0.08% 178
2018
Q1 		$958K Sell
5,620
-153
-3% -$28.1K 0.1% 170
2017
Q4 		$1M Sell
5,773
-3,160
-35% -$559K 0.1% 173
2017
Q3 		$1.67M Buy
8,933
+4,530
+103% +$803K 0.18% 127
2017
Q2 		$758K Buy
4,403
+300
+7% +$48.8K 0.08% 157
2017
Q1 		$673K Sell
4,103
-4
-0.1% -$665 0.08% 163
2016
Q4 		$600K Buy
4,107
+400
+11% +$60.2K 0.07% 167
2016
Q3 		$618K Buy
3,707
+212
+6% +$35.9K 0.08% 167
2016
Q2 		$532K Buy
3,495
+460
+15% +$71.5K 0.07% 171
2016
Q1 		$455K Buy
3,035
+49
+2% +$7.28K 0.06% 170
2015
Q4 		$485K Hold
2,986
– – 0.07% 165
2015
Q3 		$413K Hold
2,986
– – 0.06% 172
2015
Q2 		$458K Hold
2,986
– – 0.07% 179
2015
Q1 		$477K Hold
2,986
– – 0.07% 183
2014
Q4 		$476K Buy
2,986
+640
+27% +$99.7K 0.07% 176
2014
Q3 		$330K Sell
2,346
-55
-2% -$7.18K 0.05% 199
2014
Q2 		$284K Sell
2,401
-57
-2% -$6.6K 0.05% 212
2014
Q1 		$303K Hold
2,458
– – 0.05% 191
2013
Q4 		$280K Buy
2,458
+600
+32% +$68.3K 0.05% 193
2013
Q3 		$208K Buy
+1,858
New +$201K 0.04% 215

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Montag & Associates's AMGN Position: Q2 2026 in Review

Montag & Associates reduced its Amgen (AMGN) stake by 6.8% in Q2 2026, selling an estimated $68.5K and leaving 2,744 shares worth $994K. The position accounts for 0.04% of the portfolio, ranked #255.

Montag & Associates first reported a position in AMGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.79M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Montag & Associates held 2,744 shares of Amgen worth $994K as of Q2 2026.
  • Montag & Associates sold 200 Amgen shares in Q2 2026, an estimated $68.5K.
  • Amgen made up 0.04% of Montag & Associates's portfolio in Q2 2026, its #255 holding.
  • Montag & Associates first reported a position in Amgen in Q3 2013 and has held it in 52 quarters since.
  • Montag & Associates's Amgen position peaked at $1.79M in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.